Drug Information

Drug General Information
Drug ID
D0A1QJ
Former ID
DNC001421
Drug Name
Tellurium
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535625]
Structure
Download
2D MOL

3D MOL
Formula
Te
Canonical SMILES
[Te]
InChI
1S/Te
InChIKey
PORWMNRCUJJQNO-UHFFFAOYSA-N
CAS Number
CAS 11073-85-1
PubChem Compound ID
6327182
PubChem Substance ID
6233131, 7890735, 8020366, 10514260, 11600289, 15388371, 16410393, 24852275, 24855962, 24855963, 24856041, 24856140, 24868693, 24888604, 42974933, 49658636, 49854958, 50049620, 51075757, 56371253, 57365914, 77578376, 93618388, 114449275, 117682981, 118309590, 126672821, 134340529, 134340607, 134991308, 135268760, 137001630, 137171626, 137240393, 140202937, 143435218, 143472660, 143801827, 160649668, 162094955, 162271686, 162474255, 163802217, 164847921, 175266061, 176269486, 179692759, 184609360, 198988129, 204359562
Target and Pathway
Target(s) Squalene monooxygenase Target Info Inhibitor [535625]
KEGG Pathway Steroid biosynthesis
Sesquiterpenoid and triterpenoid biosynthesis
Metabolic pathways
Biosynthesis of secondary metabolites
Biosynthesis of antibiotics
PathWhiz Pathway Steroid Biosynthesis
Reactome Cholesterol biosynthesis
Activation of gene expression by SREBF (SREBP)
References
Ref 535625Squalene epoxidase as hypocholesterolemic drug target revisited. Prog Lipid Res. 2003 Jan;42(1):37-50.
Ref 535625Squalene epoxidase as hypocholesterolemic drug target revisited. Prog Lipid Res. 2003 Jan;42(1):37-50.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.